At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • December 26th, 2012 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 26th, 2012 Company Industry JurisdictionPluristem Therapeutics Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: